Join to View Full Profile
196 Parkway SouthSuite 303Waterford, CT 06385
Phone+1 860-443-4455
Dr. Kane is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Icahn School of Medicine at Mount SinaiFellowship, Hematology and Medical Oncology, 1986 - 1988
Sidney Kimmel Medical College at Thomas Jefferson University/TJUHResidency, Internal Medicine, 1984 - 1986- Sidney Kimmel Medical College at Thomas Jefferson University/TJUHInternship, Internal Medicine, 1983 - 1984
Rutgers New Jersey Medical SchoolClass of 1983
Certifications & Licensure
NY State Medical License 1986 - Present
CT State Medical License 2018 - 2026
NJ State Medical License 1990 - 2021
PA State Medical License 1984 - 2021
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Fellow American College of Physicians
Clinical Trials
- Oxaliplatin, Leucovorin Calcium, and Fluorouracil With or Without Celecoxib in Treating Patients With Stage III Colon Cancer Previously Treated With Surgery Start of enrollment: 2010 Jun 01
- Docetaxel, Carboplatin, Trastuzumab, and Pertuzumab With or Without Estrogen Deprivation in Treating Patients With Hormone Receptor-Positive, HER2-Positive Operable or Locally Advanced Breast Cancer Start of enrollment: 2014 Feb 18
Publications & Presentations
PubMed
- 14 citationsTransdermal estradiol in castrate and chemotherapy resistant prostate cancer.M. N. Stein, Susan Goodin, S. Doyle-Lindrud, Jeffery Silberberg, Michael P. Kane
Medical Science Monitor. 2012-04-01 - 9 citationsRationally Designed Treatment for Solid Tumors with MAPK Pathway Activation: A Phase I Study of Paclitaxel and Bortezomib Using an Adaptive Dose-Finding ApproachJanice M. Mehnert, Antoinette R. Tan, Rebecca A. Moss, Elizabeth Poplin, Mark N. Stein
Molecular Cancer Therapeutics. 2011-08-01
Press Mentions
FDA’s Naming Rule for Biosimilars Has Undermined Congress and Health CareOctober 4th, 2021- Connecticut's Top Doctors 2021: Over 1,500 Physicians in 66 SpecialtiesJune 1st, 2021
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
